| Viral Load - Non-Smoker |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
137 |
36.3% |
2.2% |
3 |
17.2374 |
0.0006 |
| 40 - 10000 |
76 |
20.2% |
3.9% |
3 |
| >10000 |
65 |
17.2% |
16.9% |
11 |
| unknown |
99 |
26.3% |
11.1% |
11 |
| Viral Load - Smoker |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
20 |
35.1% |
0.0% |
0 |
7.7561 |
0.0478 |
| 40 - 10000 |
15 |
40.5% |
6.7% |
1 |
| >10000 |
6 |
27.3% |
33.3% |
2 |
| unknown |
16 |
33.3% |
6.3% |
1 |
| Viral Load - CD4 cell count(< 200) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 40 - 10000 |
32 |
18.1% |
6.1% |
2 |
13.1065 |
0.0038 |
| <40 |
33 |
18.6% |
0.0% |
- |
| unknown |
66 |
37.3% |
26.1% |
17 |
| >10000 |
46 |
26.0% |
13.6% |
6 |
| Viral Load - CD4 cell count(200 - 500) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 40 - 10000 |
47 |
26.6% |
4.3% |
2 |
0.5377 |
0.9401 |
| <40 |
85 |
48.0% |
2.4% |
2 |
| unknown |
23 |
13.0% |
4.5% |
1 |
| >10000 |
22 |
12.4% |
4.3% |
1 |
| Viral Load - CD4 cell count(> 500) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
35 |
70.0% |
2.9% |
1 |
0.4286 |
1 |
| unknown |
5 |
10.0% |
0.0% |
0 |
| >10000 |
3 |
6.0% |
0.0% |
0 |
| 40 - 10000 |
7 |
14.0% |
0.0% |
0 |
Viral Load – ART
(not started) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
1 |
5.9% |
0.0% |
0 |
1.1636 |
1 |
| 40 - 10000 |
1 |
5.9% |
0.0% |
0 |
| >10000 |
0 |
0.0% |
0.0% |
0 |
| unknown |
15 |
88.2% |
40.0% |
6 |
| Viral Load – ART Type 1 |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
120 |
35.2% |
1.7% |
2 |
12.9821 |
0.0042 |
| 40 - 10000 |
73 |
21.4% |
5.5% |
4 |
| >10000 |
52 |
15.2% |
15.4% |
8 |
| unknown |
96 |
28.2% |
5.2% |
5 |
| Viral Load – ART Type 2 |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
6 |
35.3% |
0.0% |
0 |
7.5 |
0.1176 |
| 40 - 10000 |
6 |
35.3% |
0.0% |
0 |
| >10000 |
3 |
17.6% |
0.0% |
0 |
| unknown |
2 |
11.8% |
50.0% |
1 |
| Viral Load – ART Salvage |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
31 |
51.7% |
3.2% |
1 |
10.8687 |
0.0143 |
| 40 - 10000 |
11 |
18.3% |
0.0% |
0 |
| >10000 |
16 |
26.7% |
31.3% |
5 |
| unknown |
2 |
3.3% |
0.0% |
0 |
| Viral Load - Neutrophil count(<2) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
45 |
28.1% |
0.0% |
0 |
6.9433 |
0.063 |
| 40 - 10000 |
40 |
25.0% |
7.5% |
3 |
| >10000 |
33 |
20.6% |
15.2% |
5 |
| unknown |
42 |
26.3% |
11.9% |
5 |
| Viral Load - Neutrophil count(≥2) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <40 |
100 |
46.1% |
3.0% |
3 |
11.4183 |
0.0087 |
| 40 - 10000 |
40 |
18.4% |
2.5% |
1 |
| >10000 |
32 |
14.7% |
18.8% |
6 |
| unknown |
45 |
20.7% |
8.9% |
4 |
| Neutrophil Count – Age(20 - 30) |
All Patients |
Percentage |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
26 |
32.1% |
3.8% |
1 |
0.5982 |
0.7415 |
| ≥2 |
48 |
59.3% |
6.3% |
3 |
| unknown |
7 |
8.6% |
0.0% |
- |
| Neutrophil Count – Age(31 - 40) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
66 |
36.1% |
6.1% |
4 |
1.783 |
0.4375 |
| ≥2 |
89 |
48.6% |
7.9% |
7 |
| unknown |
28 |
15.3% |
14.3% |
4 |
| Neutrophil Count – Age(41 - 50) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
47 |
39.5% |
10.6% |
5 |
2.2398 |
0.3828 |
| ≥2 |
61 |
51.3% |
4.9% |
3 |
| unknown |
11 |
9.2% |
0.0% |
- |
| Neutrophil Count – Age(51 - 60) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
19 |
41.3% |
15.8% |
3 |
0.899 |
0.8303 |
| ≥2 |
17 |
37.0% |
5.9% |
1 |
| unknown |
10 |
21.7% |
10.0% |
1 |
| Neutrophil Count - CD4(<200) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
76 |
42.9% |
11.8% |
9 |
0.7827 |
0.6982 |
| ≥2 |
80 |
45.2% |
12.5% |
10 |
| unknown |
21 |
11.9% |
19.0% |
4 |
| Neutrophil Count - CD4(200 - 500) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
74 |
41.8% |
4.1% |
3 |
0.5877 |
1 |
| ≥2 |
89 |
50.3% |
3.4% |
3 |
| unknown |
14 |
7.9% |
0.0% |
- |
| Neutrophil Count - CD4(> 500) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| <2 |
4 |
8.0% |
0.0% |
- |
0.2195 |
1 |
| ≥2 |
41 |
82.0% |
2.4% |
1 |
| unknown |
5 |
10.0% |
0.0% |
- |
| CD4 count - No. of years diagnosed with HIV (0-7) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 200 - 500 |
149 |
38.6% |
2.7% |
4 |
11.2656 |
0.0121 |
| <200 |
165 |
42.7% |
11.5% |
19 |
| > 500 |
44 |
11.4% |
2.3% |
1 |
| unknown |
28 |
7.3% |
7.1% |
2 |
| CD4 count - No. of years diagnosed with HIV (8-13) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 200 - 500 |
20 |
54.1% |
10.0% |
2 |
3.5325 |
0.3909 |
| <200 |
10 |
27.0% |
30.0% |
3 |
| > 500 |
5 |
13.5% |
0.0% |
0 |
| unknown |
2 |
5.4% |
0.0% |
0 |
| CD4 count - No. of years diagnosed with HIV (>14) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 200 - 500 |
7 |
70.0% |
0.0% |
0 |
9 |
0.3 |
| <200 |
1 |
10.0% |
100.0% |
1 |
| > 500 |
1 |
10.0% |
0.0% |
0 |
| unknown |
1 |
10.0% |
0.0% |
0 |
| CD4 count – Gender(F) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 200 - 500 |
128 |
43.1% |
1.6% |
2 |
17.0343 |
0.0014 |
| <200 |
103 |
34.7% |
14.6% |
15 |
| > 500 |
44 |
14.8% |
2.3% |
1 |
| unknown |
22 |
7.4% |
9.1% |
2 |
| CD4 count – Gender(M) |
All Patients |
% |
OLSAH |
Chi Square Test |
P-Value |
| 200 - 500 |
47 |
35.1% |
8.5% |
4 |
1.8831 |
0.6001 |
| <200 |
72 |
53.7% |
11.1% |
8 |
| > 500 |
6 |
4.5% |
0.0% |
0 |
| unknown |
9 |
6.7% |
0.0% |
0 |
